NCT03443453

A Bioavailability Study of MIV-711 Oral Formulations in Healthy Volunteers

A Single-Center, Randomised, 4-Period, Phase 1 Study to Evaluate the Pharmacokinetics, Safety and Tolerability, and Effect of Food on Pharmacokinetics Following Single Doses of MIV-711 Capsule and Tablet Formulations in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 18 (actual)
• Sponsor: Medivir · Industry
• Sex: All
• Age: 19 Years – 55 Years
• Healthy volunteers: Accepted

Summary

This is a single-Center, Randomised, 4-Period, Phase 1 Study to Evaluate the Pharmacokinetics, Safety and Tolerability, and Effect of Food on Pharmacokinetics following Single Doses of MIV-711 Capsule and Tablet Formulations in Healthy Volunteers

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	MIV-711	MIV-711 administered as tablets and capsules at four occasions

Timeline

• Start date: 2018-01-19
• Primary completion: 2018-02-17
• Completion: 2018-02-17
• First posted: 2018-02-23
• Last updated: 2018-02-23

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study